166 related articles for article (PubMed ID: 24312625)
1. Phosphorylation of ASPP2 by RAS/MAPK pathway is critical for its full pro-apoptotic function.
Godin-Heymann N; Wang Y; Slee E; Lu X
PLoS One; 2013; 8(12):e82022. PubMed ID: 24312625
[TBL] [Abstract][Full Text] [Related]
2. ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells.
Wang Y; Godin-Heymann N; Dan Wang X; Bergamaschi D; Llanos S; Lu X
Cell Death Differ; 2013 Apr; 20(4):525-34. PubMed ID: 23392125
[TBL] [Abstract][Full Text] [Related]
3. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
[TBL] [Abstract][Full Text] [Related]
4. N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.
Wang Z; Liu Y; Takahashi M; Van Hook K; Kampa-Schittenhelm KM; Sheppard BC; Sears RC; Stork PJ; Lopez CD
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):312-7. PubMed ID: 23248303
[TBL] [Abstract][Full Text] [Related]
5. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins.
Benyamini H; Friedler A
J Mol Recognit; 2011; 24(2):266-74. PubMed ID: 20623514
[TBL] [Abstract][Full Text] [Related]
6. [Phosphorylation status of ASPP2 modulates p53 apoptotic function in oxaliplatin-induced apoptosis of colorectal cancer HCT116 cells].
Hou Q; Zhao H; Gong W; Zhu Z; Han Y; Chen D; Guo H
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):418-23. PubMed ID: 25241782
[TBL] [Abstract][Full Text] [Related]
7. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2).
Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E
J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740
[TBL] [Abstract][Full Text] [Related]
8. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins.
Ahn J; Byeon IL; Byeon CH; Gronenborn AM
J Biol Chem; 2009 May; 284(20):13812-13822. PubMed ID: 19246451
[TBL] [Abstract][Full Text] [Related]
9. ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.
Van Hook K; Wang Z; Chen D; Nold C; Zhu Z; Anur P; Lee HJ; Yu Z; Sheppard B; Dai MS; Sears R; Spellman P; Lopez CD
Biochem Biophys Res Commun; 2017 Jan; 482(4):1271-1277. PubMed ID: 27939881
[TBL] [Abstract][Full Text] [Related]
10. Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax.
Patel S; George R; Autore F; Fraternali F; Ladbury JE; Nikolova PV
Nucleic Acids Res; 2008 Sep; 36(16):5139-51. PubMed ID: 18676979
[TBL] [Abstract][Full Text] [Related]
11. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53.
Lee SW; Fang L; Igarashi M; Ouchi T; Lu KP; Aaronson SA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8302-5. PubMed ID: 10890907
[TBL] [Abstract][Full Text] [Related]
12. Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway.
Mazzoni IE; Saïd FA; Aloyz R; Miller FD; Kaplan D
J Neurosci; 1999 Nov; 19(22):9716-27. PubMed ID: 10559381
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host.
Buti L; Spooner E; Van der Veen AG; Rappuoli R; Covacci A; Ploegh HL
Proc Natl Acad Sci U S A; 2011 May; 108(22):9238-43. PubMed ID: 21562218
[TBL] [Abstract][Full Text] [Related]
14. Control of ASPP2/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function.
Zhu Z; Ramos J; Kampa K; Adimoolam S; Sirisawad M; Yu Z; Chen D; Naumovski L; Lopez CD
J Biol Chem; 2005 Oct; 280(41):34473-80. PubMed ID: 16091363
[TBL] [Abstract][Full Text] [Related]
15. ASPP1 and ASPP2: common activators of p53 family members.
Bergamaschi D; Samuels Y; Jin B; Duraisingham S; Crook T; Lu X
Mol Cell Biol; 2004 Feb; 24(3):1341-50. PubMed ID: 14729977
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to cell death induced by blockade of MAPK pathway in human colorectal cancer cells carrying Ras mutations is dependent on p53 status.
Wang Z; Li Y; Liu ET; Yu Q
Biochem Biophys Res Commun; 2004 Sep; 322(2):609-13. PubMed ID: 15325273
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase.
Shih A; Lin HY; Davis FB; Davis PJ
Biochemistry; 2001 Mar; 40(9):2870-8. PubMed ID: 11258898
[TBL] [Abstract][Full Text] [Related]
19. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
[TBL] [Abstract][Full Text] [Related]
20. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]